Left Atrial Appendage
Morbid obesity tied to risk for complications in LAA closure
In patients with atrial fibrillation who underwent percutaneous left atrial appendage closure for stroke prevention, morbid obesity was associated with higher odds of complications and longer length of stay, researchers reported.
LAAO device usage up, major adverse events down over time
From 2016 to 2019, percutaneous left atrial appendage occlusion procedures for stroke prevention rose and major adverse events associated with them fell, according to a real-world analysis published in HeartRhythm.
Data show LAA closure safe in nonvalvular AF with HF
A database review showed left atrial appendage closure with the Watchman device is safe in adults with HF and atrial fibrillation, who experienced in-hospital mortality and CV complication rates similar to those without HF.
VIDEO: Itchhaporia discusses TCT late-breakers Amulet IDE, CLASP IID and PROTECTED TAVR
BOSTON — In this Healio video exclusive, Dipti Itchhaporia, MD, FACC, FESC, discusses some of the highlights in late breaking science presented at TCT 2022.
At 3 years, Amulet device for LAAO remains noninferior for safety, efficacy vs. Watchman
BOSTON — At 3 years, the Amplatzer Amulet device remained superior at left atrial appendage occlusion and noninferior for safety and effectiveness compared with the Watchman device, researchers reported at TCT 2022.
FDA expands LAA closure device labeling to include 45-day DAPT option
Boston Scientific announced the FDA indication for its left atrial appendage closure device has been expanded to include a 45-day dual antiplatelet therapy option after treatment of patients with nonvalvular atrial fibrillation.
LIGATE
Feasibility and safety profile of a second-generation LAAC device (Ultraseal, Cardia) in nonvalvular atrial fibrillation.
In AF, LAA closure may be best suited for patients at low stroke risk, high bleeding risk
In a decision analysis comparing left atrial appendage occlusion and oral anticoagulation in atrial fibrillation, left atrial appendage occlusion tended to be favored when patients were at low risk for stroke and high risk for bleeding.
Same-day discharge may be safe after LAA closure without complications
Same-day discharge did not raise risk for readmission in patients with atrial fibrillation who underwent left atrial appendage closure without complications, researchers reported.
Next-generation LAA closure device ‘promising alternative’ for adults with nonvalvular AF
Among patients with nonvalvular atrial fibrillation, left atrial appendage closure with a second‐generation device was associated with high success rates and a low risk for procedure‐related adverse events, researchers reported.